Stock CNTB CONNECT BIOPHARMA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Connect Biopharma Holdings Limited

Equities

CNTB

US2075231017

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 02:00:00 02/05/2024 am IST 		5-day change 1st Jan Change
1.43 USD +2.88% Intraday chart for Connect Biopharma Holdings Limited +2.88% +21.19%
17/04 Sector Update: Health Care Stocks Retreating Late Afternoon MT
17/04 Sector Update: Health Care MT

Business Summary

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of T cell-driven inflammatory diseases. The Company’s lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Ra) in development for the treatment of atopic dermatitis and asthma. Its second advanced product candidate, CBP-307, is a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis (UC). The Company’s third product candidate, CBP-174, is a peripherally acting antagonist of histamine receptor 3, in development for the treatment of pruritus associated with atopic dermatitis (AD). It has clinical development activities in the United States, the People’s Republic of China (PRC), Europe, and Australia and operations in those geographies, as well as Hong Kong. Its subsidiaries include Connect Biopharma HongKong Limited, Connect Biopharm LLC and others.

Number of employees: 81

Managers

Managers TitleAgeSince
Zheng Wei FOU
 Founder 61 23/15/23
Wubin Pan FOU
 Founder 60 01/12/01
Steven Chan DFI
 Director of Finance/CFO 52 22/21/22
Raul Collazo CTO
 Chief Tech/Sci/R&D Officer - 01/21/01
Jiang Bian CMP
 Compliance Officer - 20/21/20
Lei Sun PRN
 Corporate Officer/Principal 60 01/20/01

Members of the board

Members of the board TitleAgeSince
Jean Liu BRD
 Director/Board Member 55 23/21/23
Kleanthis Xanthopoulos BRD
 Director/Board Member 66 01/20/01
Karen Wilson BRD
 Director/Board Member 61 01/20/01
Zuie Chin Huang BRD
 Director/Board Member 58 12/02
Wubin Pan FOU
 Founder 60 01/12/01
Zheng Wei FOU
 Founder 61 23/15/23
Kan Chen BRD
 Director/Board Member 42 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 59,914,136 33,745,153 ( 56.32 %) 2,405,591 ( 4.015 %) 56.32 %

Shareholders

NameEquities%Valuation
RA Capital Management LP
5.562 %
3,062,871 5.562 % 5 M $
BML Capital Management LLC
3.743 %
2,061,338 3.743 % 4 M $
BlackRock Advisors LLC
1.889 %
1,040,067 1.889 % 2 M $
UBS O'Connor LLC
1.019 %
561,191 1.019 % 976 472 $
Renaissance Technologies LLC
0.5411 %
298,000 0.5411 % 518 520 $
Andbank Wealth Management SGIIC SAU
0.0545 %
30,002 0.0545 % 52 203 $
Geode Capital Management LLC
0.0508 %
27,961 0.0508 % 48 652 $
Commonwealth Equity Services LLC
0.0363 %
20,000 0.0363 % 34 800 $
RhumbLine Advisers LP
0.0300 %
16,520 0.0300 % 28 745 $
XTX Topco Ltd.
0.0282 %
15,506 0.0282 % 26 980 $
NameEquities%Valuation
Panacea Venture
21.79 %
12,000,000 21.79 % 21 M $
Wubin Pan
11.25 %
6,197,398 11.25 % 11 M $
Zheng Wei
10.76 %
5,928,164 10.76 % 10 M $
Jian Ping Gu
9.634 %
5,306,149 9.634 % 9 M $
Qiming US Ventures Management, LLC
8.789 %
4,840,898 8.789 % 8 M $
Advantech Advisors (HK) Limited
8.647 %
4,762,185 8.647 % 8 M $
LAV Management Co., Ltd.
6.059 %
3,336,907 6.059 % 6 M $
Karen Wilson
0.0182 %
10,000 0.0182 % 17 400 $
Steven Chan
0.004539 %
2,500 0.004539 % 4 350 $
Kleanthis Xanthopoulos
0.000000 %
0 0.000000 % - $

Company contact information

Connect Biopharma Holdings Ltd.

Science & Technology Park 3/F, East R&D Building

215400, Taicang

+

http://www.connectbiopharm.com
address Connect Biopharma Holdings Limited(CNTB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.39 USD
Average target price
7 USD
Spread / Average Target
+403.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CONNECT BIOPHARMA HOLDINGS LIMITED Stock Connect Biopharma Holdings Limited
+21.19% 76.59M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.17% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.87% 96.09B
ARGENX SE Stock argenx SE
+2.13% 22.28B
BIONTECH SE Stock BioNTech SE
-14.77% 21.4B
GENMAB A/S Stock Genmab A/S
-8.79% 18.14B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.09B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+8.55% 13.83B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.75% 11.97B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CNTB Stock
  4. Company Connect Biopharma Holdings Limited